Active Clinical Trials
Clinical trials are at the heart of our work to bring innovative medicines to people with a particular disease or condition. Learn more about the active studies conducted by Novartis including opportunities to get involved.
- Sort by Sort ascending
- Study title
- Condition
- Phase
- Location
Study title | Condition | Phase | Location | |
---|---|---|---|---|
Efficacy and Safety of Switching From Anti-C5 Antibody Treatment to Iptacopan Treatment in Study Participants With Atypical Hemolytic Uremic Syndrome (aHUS) |
Atypical Hemolytic Uremic Syndrome | Phase3 | China Japan Spain Turkey United Kingdom View All |
NCT05935215 |
Study of Efficacy and Safety of Ribociclib (LEE011) in Combination With Topotecan and Temozolomide (TOTEM) in Pediatric Patients With Relapsed or Refractory Neuroblastoma and Other Solid Tumors |
Neuroblastoma | Phase1, Phase2 | Australia France Germany Singapore Spain United Kingdom United States View All |
NCT05429502 |
Alpelisib in Pediatric and Adult Patients With Lymphatic Malformations Associated With a PIK3CA Mutation. |
Lymphatic Malformations | Phase2, Phase3 | Australia Belgium France Germany Italy Spain United States View All |
NCT05948943 |
A Study to Investigate Efficacy, Safety, and Tolerability of Remibrutinib Compared With Placebo in Adults With CINDU Inadequately Controlled by H1-antihistamines |
Chronic Inducible Urticaria | Phase3 | Argentina Australia Brazil Canada Colombia France Germany Hong Kong Hungary India Israel Italy Japan Korea, Republic of Malaysia Netherlands Poland Portugal Romania Singapore Slovakia Spain Thailand Turkey United Kingdom United States Vietnam View All |
NCT05976243 |
A Non-interventional Implementation Study to Evaluate Treatment With Inclisiran (Leqvio®) and Other Lipid Lowering Treatments in a Real-world Setting |
Hypercholesterolemia | Germany | NCT05362903 | |
Study to Determine the Dose and Safety of Asciminib in Pediatric Patients With Chronic Myeloid Leukemia |
Myeloid Leukemia, Philadelphia Positive | Phase1, Phase2 | China France Germany Greece Hungary Italy Japan Korea, Republic of Netherlands Poland Russian Federation Thailand Turkey United States View All |
NCT04925479 |
Ofatumumab in Portuguese Multiple Sclerosis Patients - an Observational Study |
Relapsing Multiple Sclerosis | Portugal | NCT05809986 | |
A Phase IV Study of Safety and Efficacy of Everolimus in Taiwanese Patients With Tuberous Sclerosis Complex Who Have Renal Angiomyolipoma (TSC-AML) |
Renal Angiomyolipoma | Phase4 | Taiwan | NCT05252585 |
Early Versus Late Ofatumumab (Kesimpta®) Use in Austrian RMS-Patients Over 2 Years |
Relapsing Multiple Sclerosis | Austria | NCT05776888 | |
A Randomized, Double-blind 2-arm NEPTUNUS Extension Study to Assess the Long-term Safety and Efficacy of Ianalumab in Patients With Sjogrens Syndrome. |
Sjogrens Syndrome | Phase3 | Argentina Australia Austria Brazil Bulgaria Canada Chile China Colombia Czechia France Germany Greece Guatemala Hungary India Israel Italy Japan Korea, Republic of Lithuania Mexico Poland Portugal Romania Singapore Slovakia South Africa Spain Sweden Taiwan Turkey United Kingdom United States View All |
NCT05985915 |
Pagination
- ‹‹ Previous page
- 1
- …
- 11
- 12
- 13
- 14
- 15
- 16
- 17
- ›› Next page